Enhancement of the immunogenicity of DNA replicon vaccine ofClostridium botulinumneurotoxin serotype A byGM-CSFgene adjuvant

Co-administration of a CpG adjuvant (VaxImmuneTM, CPG 7909) with CETP vaccines increased immunogenicity in rabbits and mice

(2010) Lawrence J. Thomas et al.   Human vaccines & immunotherapeutics

Improved immunogenicity and protective efficacy of a replicon DNA vaccine encoding the Hc domain of botulinum neurotoxin serotype A by electric pulses and protein boosting

(2009) Yun-Zhou Yu et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors

(2009) Yunzhou Yu et al.   VACCINE

The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate

(2009) Yun-Zhou Yu et al.   VACCINE

Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity

(2008) Matthias Tenbusch et al.   BMC IMMUNOLOGY

Evaluation of a Recombinant Hc of Clostridium botulinum Neurotoxin Serotype F as an Effective Subunit Vaccine

(2008) Y.-Z. Yu et al.   Clinical and Vaccine Immunology

Protection with a recombinant Hc ofClostridium Botulinumneurotoxin serotype A fromEscherichia colias an effective subunit vaccine

(2008) Yun-Zhou Yu et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced Melanoma

(2008) Miguel-Angel Perales et al.   MOLECULAR THERAPY